Sparks DL, Connor DJ, Browne PJ, Lopez JE, Sabbagh MN.
HMG-CoA reductase inhibitors (statins) in the treatment of Alzheimer's disease and why it would be ill-advise to use one that crosses the blood-brain barrier.J Nutr Health Aging.
2002;6(5):324-31.
PubMed Abstract
Interesting speculation but the proof will be in the pudding. Ultimately, we don't yet know what happens when statins are given to normal cholesterolemic individuals.